SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001607062-15-000187
Filing Date
2015-04-27
Accepted
2015-04-27 16:00:40
Documents
1
Period of Report
2015-04-27

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT gnbt42715form4.html 4  
1 OWNERSHIP DOCUMENT gnbt42715form4.xml 4 11677
  Complete submission text file 0001607062-15-000187.txt   13056
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Issuer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
SIC: 2834 Pharmaceutical Preparations

Mailing Address 555 RICHMOND ST. W, SUITE 604 TORONTO A6 M5V3B1
Business Address
BARRATT JOHN P (Reporting) CIK: 0001270529 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-25169 | Film No.: 15795188